prefilled syringe (PFS) with a needle safety device. Each device delivers 0.9 mL (162 mg) ...
Actemra (tocilizumab) is a FDA approved biological medicine that is given by intravenous infusion or injection under the skin to treat specific patients with COVID-19, rheumatoid arthritis, giant cell arteritis, scleroderma, polyarticular or systemic juvenile idiopathic arthritis, and severe cytokine ...
The recommended injection sites are the front and middle of your thighs and the lower part of the abdomen below the navel (belly button), except for the five-centimetre area directly around the navel. If a caregiver is giving the injection, the outer area of the upper arms may also be us...
Actemra ACTPen (tocilizumab) Injection; Subcutaneous More information please phone:800-675-8416Visit Website Provider: Patient Access Network Foundation (PAN) Eligibility requirements: *See Additional Information section below Between 400-500% of FPL ...
Actemra(托珠单抗)在治疗COVID-19患者中的应用托珠单抗(Actemra,通用名:托珠单抗)可能改善正在接受皮质类固醇治疗且需要额外氧气或呼吸支持的COVID-19患者的预后。托珠单抗已被美国食品药品监督管理局(FDA)批准用于治疗住院成人患者,这些患者正在接受全身性皮质类固醇治疗,并且需要额外氧气、无创或有创机械通气或体外膜氧合...
Actemra is supplied as a sterile, preservative-free solution for intravenous (IV) infusion at a concentration of 20 mg/mL. Actemra is a colorless to pale yellow liquid, with a pH of about 6.5. Single-use vials are available containing 80 mg/4 mL, 200 mg/10 mL, or 400 mg/20 mL of...
Patients using ACTEMRA for subcutaneous administration should be instructed to inject the full amount in the syringe (0.9 mL), which provides 162 mg of ACTEMRA, according to the directions provided in the IFU. Injection sites should be rotated with each injection and should never be given into ...
The development of ACTEMRA 162 mg Syringe/Auto-Injector for SC Injection On the development of subcutaneous injection form of antibody drugs, small injection volume (i.e. 1mL) is the key achievement for enabling subcutaneous inj... Y Imaeda,D Kameoka,H Yamada - 《Pda Journal of Gmp & Vali...
162mg/0.9mL (Actemra) injection, single-use prefilled syringe for SC 162mg/0.9mL (Actemra, Tyenne) Biosimilars to Actemra Tofidence (tocilizumab-bavi) Tyenne (tocilizumab-aazg) Rheumatoid Arthritis Actemra, Tofidence, Tyenne Indicated for adults with moderate-to-severe active rheumatoid arthritis...
Actemra(托珠单抗)在治疗COVID-19患者中的应用托珠单抗(Actemra,通用名:托珠单抗)可能改善正在接受皮质类固醇治疗且需要额外氧气或呼吸支持的COVID-19患者的预后。托珠单抗已被美国食品药品监督管理局(FDA)批准用于治疗住院成人患者,这些患者正在接受全身性皮质类固醇治疗,并且需要额外氧气、无创或有创机械通气或体外膜氧合...